Session Datesort descending
Head and Neck Cancer Tumor Board -1/4/23 01/04/2023 - 6:30am to 8:00am CST
Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311), January 30th, 2023 01/30/2023 - 8:00am to 9:00pm CST
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma - 3/6/23 03/06/2023 - 8:00am to 9:00pm CST
Frameless Stereotactic Radiosurgery in the Gamma Knife Icon: Early Experience From 100 Patients, April 10th, 2023 04/10/2023 - 8:00am to 9:00pm CDT
A National Cancer Disparities Analysis of Predictors for Radiation Therapy Refusal by Race, April 18th, 2023 04/18/2023 - 8:00am to 9:00pm CDT
Upfront Radiosurgery vs a Wait-and-Scan Approach for Small or Medium-Sized Vestibular Schwannoma: The V-REX Randomized Clinical Trial, October 10th, 2023 10/10/2023 - 8:00am to 9:00pm CDT
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: Systemic review and consensus recommendations by the EORTC-ESTRO OligoCare consortium, November 10th, 2023 11/10/2023 - 8:00am to 9:00am CST
Human Oncology Journal Club (2023) - Planning Committee Disclosure 02/29/2024 - 11:00pm to 11:59pm CST